Controlled process reliability with GEMÜ SUMONDO®
(PresseBox) - GEMÜ, the leading manufacturer of valves, measurement and control systems for the pharmaceutical industry, has developed the world''s first Single-Use diaphragm valve. GEMÜ SUMONDO® represents the long-awaited paradigm change to Single-Use design: From manual systems to automation-capable and controllable plants for faultless operation and continual documentation by the plant monitoring system.
The trend towards simplified upstream and downstream plant designs and the effective prevention of cross-contamination risks means that Single-Use disposable technology is becoming an increasingly high-profile and important field - especially in pharmaceutical process engineering. Single-Use design is increasingly being used particularly in the manufacture of smaller batch sizes, which are required, for example, in research and pilot plants.
CIP/SIP processes are no longer required
The secondary processes for cleaning and sterilisation (CIP/SIP) that are well-known and required for classic stainless material plant designs are in practice no longer necessary at all with Single-Use plants and processes. The necessary purity is guaranteed through the sterilization by gamma rays of all the process components used. This not only reduces the investment costs of such a plant, but also eliminates extremely time-consuming cleaning validation for operating media that are no longer required.
GEMÜ SUMONDO® links the valve body and actuator together using patent-pending locking technology: After the application process, only the valve body is removed, the actuator itself can be reused repeatedly in the plant.
The valve body is manufactured from polypropylene in a cleanroom and is gamma irradiated up to 50 kGy. It isolates the working medium hermetically from the environment and from the actuator through an ultrasonically welded TPE diaphragm. The medium remains closed off from the environment by the welded diaphragm not only during operation, but also after removing the valve body.
Reproducible and documentable procedures
The major advantage of GEMÜ SUMONDO ® in comparison with conventional pinch valves lies in the exact controllability of processes. Using a tried and tested actuator design from conventional plant engineering, the actuator can also transmit feedback to the plant monitoring system as required to ensure complete monitoring of the controlled system. This means that pharmaceutical processes can be more easily documented, reproduced and validated.
The increased levels of automation also mean that the systems are less likely to have faults.
GEMÜ SUMONDO® is initially available in three valve body versions in the nominal sizes 3/8" to 1" with hose barb or clamp connection. The body is available as a straight way, T- and angle valve (right) design. The products are already in use in several testing facilities at development partners.
GEMÜ is one of the world''s leading manufacturers of valves, measurement and control systems. Over the course of 50 years, this globally focused, independent family owned enterprise has established itself in important industrial sectors thanks to its innovative products and customised solutions for process media control. GEMÜ is the world market leader for sterile valve applications in the pharmaceutical industry and biotechnology industries.
Today, the GEMÜ Group employs over 800 employees in Germany and more than 1400 worldwide. Manufacturing is carried out at six manufacturing sites in Germany, Switzerland, China, Brazil, France and the USA. From Germany we coordinate global marketing with 24 subsidiaries and with a large distributor network in 53 markets, the GEMÜ Group is active on all five continents. GEMÜ will continue to establish itself in future markets with its international growth strategy. To achieve this, GEMÜ has opened a new Production and Logistics Centre in 2013.
A broad based modular system and adapted automation components mean that predefined standard products and customised solutions can be combined to make over 400,000 product versions.
Further information can be found at www.gemu-group.com.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
GEMÜ is one of the world''s leading manufacturers of valves, measurement and control systems. Over the course of 50 years, this globally focused, independent family owned enterprise has established itself in important industrial sectors thanks to its innovative products and customised solutions for process media control. GEMÜ is the world market leader for sterile valve applications in the pharmaceutical industry and biotechnology industries.
Today, the GEMÜ Group employs over 800 employees in Germany and more than 1400 worldwide. Manufacturing is carried out at six manufacturing sites in Germany, Switzerland, China, Brazil, France and the USA. From Germany we coordinate global marketing with 24 subsidiaries and with a large distributor network in 53 markets, the GEMÜ Group is active on all five continents. GEMÜ will continue to establish itself in future markets with its international growth strategy. To achieve this, GEMÜ has opened a new Production and Logistics Centre in 2013.
A broad based modular system and adapted automation components mean that predefined standard products and customised solutions can be combined to make over 400,000 product versions.
Further information can be found at www.gemu-group.com.
Datum: 21.08.2014 - 07:43 Uhr
Sprache: Deutsch
News-ID 1301718
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
Ingelfingen-Criesbach
Phone:
Kategorie:
Family
Anmerkungen:
Diese Pressemitteilung wurde bisher 210 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Controlled process reliability with GEMÜ SUMONDO®
"
steht unter der journalistisch-redaktionellen Verantwortung von
GEMÜ Gebr. Müller Apparatebau GmbH&Co. KG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
